Yuji Shirakata Selected Research

Yuji Shirakata Research Topics

Disease

8	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 06/2004
4	Pemphigus (Pemphigus Vulgaris) 03/2017 - 05/2005
4	Inflammation (Inflammations) 05/2016 - 04/2010
4	Virus Diseases (Viral Diseases) 05/2009 - 09/2005
3	Blister (Bulla) 03/2017 - 05/2005
3	Wounds and Injuries (Trauma) 05/2012 - 06/2005
3	Infections 03/2011 - 07/2006
2	Neoplasms (Cancer) 04/2012 - 11/2009
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 03/2011 - 04/2009
2	Hypersensitivity (Allergy) 03/2011 - 03/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2003 - 05/2003
1	Bronchiolitis Obliterans 04/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 04/2016
1	Skin Neoplasms (Skin Cancer) 04/2013
1	Pathologic Processes 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Atopic Dermatitis (Atopic Eczema) 01/2013
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 06/2011
1	Drug-Related Side Effects and Adverse Reactions 03/2011
1	Burns 12/2009
1	Prodromal Symptoms 04/2009
1	Herpes Zoster 09/2005
1	Skin Diseases (Skin Disease) 12/2004
1	Ovarian Neoplasms (Ovarian Cancer) 05/2003
1	Myeloid Leukemia (Leukemia, Myelocytic) 04/2003
1	Bullous Pemphigoid (Pemphigoid) 12/2002

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 03/2017 - 12/2002
3	CytokinesIBA 01/2013 - 04/2003
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 10/2009
2	Interleukin-22 (IL-22)IBA 01/2018 - 10/2009
2	AntibodiesIBA 03/2017 - 04/2012
2	Immunoglobulin G (IgG)IBA 03/2017 - 05/2005
2	AutoantibodiesIBA 03/2017 - 05/2005
2	SteroidsIBA 04/2016 - 04/2009
2	Epidermal Growth Factor (EGF)IBA 04/2013 - 06/2003
2	interleukin-22 receptor (IL-22R)IBA 07/2012 - 10/2009
2	Desmoglein 3IBA 04/2012 - 05/2005
2	Therapeutic UsesIBA 04/2010 - 05/2003
2	ChemokinesIBA 10/2009 - 07/2008
2	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 07/2008 - 07/2006
2	Double-Stranded RNA (RNA, Double Stranded)IBA 07/2008 - 07/2006
2	Chemokine CCL3IBA 07/2006 - 09/2005
1	Desmoglein 1IBA 03/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016
1	Prednisolone (Predate)FDA LinkGeneric 04/2016
1	Rituximab (Mabthera)FDA Link 04/2016
1	Intravenous Immunoglobulins (IVIG)FDA Link 04/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2016
1	Vincristine (Oncovin)FDA LinkGeneric 04/2016
1	Immunoglobulins (Immunoglobulin)IBA 04/2016
1	Etretinate FDA Link 05/2014
1	Messenger RNA (mRNA)IBA 04/2013
1	CollagenIBA 01/2013
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	ErbB Receptors (EGF Receptor)IBA 05/2012
1	LigandsIBA 05/2012
1	AnnexinsIBA 05/2012
1	PlakinsIBA 04/2012
1	EpitopesIBA 04/2012
1	Collagen Type VIIIBA 06/2011
1	InflammasomesIBA 03/2011
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2011
1	AllergensIBA 03/2011
1	Pharmaceutical PreparationsIBA 03/2011
1	HLA-A Antigens (HLA-A)IBA 03/2011
1	Carbamazepine (Tegretol)FDA LinkGeneric 03/2011
1	Interleukin-18 (Interleukin 18)IBA 03/2011
1	Antimicrobial PeptidesIBA 12/2010
1	Interleukin-27 (Interleukin 27)IBA 04/2010
1	Biocompatible Materials (Biomaterials)IBA 12/2009
1	Indicators and Reagents (Reagents)IBA 11/2009
1	interleukin 20 (IL-20)IBA 10/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2009
1	GlucocorticoidsIBA 05/2009
1	Poly I-CIBA 07/2006
1	Antiviral Agents (Antivirals)IBA 07/2006
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2006
1	CC ChemokinesIBA 09/2005
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 06/2005
1	Biological ProductsIBA 05/2005
1	Monoclonal AntibodiesIBA 05/2005
1	DesmogleinsIBA 05/2005
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2004
1	Calcitriol (Calcijex)FDA LinkGeneric 06/2004
1	hydroxide ionIBA 06/2004
1	MidkineIBA 05/2003
1	ElementsIBA 05/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2003
1	DNA (Deoxyribonucleic Acid)IBA 05/2003

Therapy/Procedure

2	Therapeutics 04/2016 - 05/2003